Lupin Receives USFDA Nod for Seizure Treatment Drug
Mumbai based pharmaceutical major Lupin Ltd on Wednesday announced that it has received approval from the U.S. Food and Drug Administration to market a generic medication used in the treatment of seizures in the United States.The approval...
anda
brivaracetam
briviact
bse
drugapproval
generic medication
india
lupin
oral solution
pharmaceutical industry
pharmaceutical sales
seizures
us market
usfda
